Literature DB >> 3221900

The first agonist and antagonist burst in patients with an upper motor neuron syndrome.

S Fagioli1, A Berardelli, M Hallett, N Accornero, M Manfredi.   

Abstract

Rapid elbow flexion movements were studied in patients with an upper motor neuron syndrome following a stroke. The velocity of movements was slower than normal. The initial bursts of electromyographic (EMG) activity in both the agonist and antagonist muscles were prolonged. As in normal subjects, the first agonist burst increased in duration with larger movements, but it generally remained about 40 ms longer than normal. The size of the first agonist burst also increased with larger movements. A fixed linkage between burst duration and level of motor unit recruitment, together with a deficient corticospinal command, could explain the prolonged burst duration with preserved ability to modulate the burst.

Entities:  

Mesh:

Year:  1988        PMID: 3221900     DOI: 10.1002/mds.870030204

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  4 in total

1.  Physiological analysis of simple rapid movements in patients with cerebellar deficits.

Authors:  M Hallett; A Berardelli; J Matheson; J Rothwell; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

2.  Pathological stretch reflexes on the "good" side of hemiparetic patients.

Authors:  A F Thilmann; S J Fellows; E Garms
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-03       Impact factor: 10.154

3.  Rapid elbow movements in patients with torsion dystonia.

Authors:  W van der Kamp; A Berardelli; J C Rothwell; P D Thompson; B L Day; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-09       Impact factor: 10.154

4.  Abnormal leg muscle latencies and relationship to dyscoordination and walking disability after stroke.

Authors:  Janis J Daly; Kristen Roenigk; Roger Cheng; Robert L Ruff
Journal:  Rehabil Res Pract       Date:  2010-12-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.